GSK is one of the top 5 largest pharmaceutical companies in the world. Has a global presence by operating in 120 countries and products are sold in more than 150 countries. GSK is one of the world’s largest investors in R&D and the UKs biggest private sector funder of R&D. This leads to discovering new medicine and vaccinations (Cervical cancer, bird flu) Has over 97,000 employees.
Wide range of fast selling products from medicines to soft drinks. Produces medicine and vaccinations against worldwide diseases such as malaria, TB AND HIV/AIDS Has 7% of the world pharmaceutical market.
Controversies regarding safety of drugs affect the company’s image for example GSKs product Avantia which was taken off the market due to its undesirable effects to the cardio system. Highly concentrated on the UK pharmaceutical market.
Environmental impacts of production of certain drugs like amoxicillin. More expensive range of products in comparison with non-original companies Opportunities
GSK could penetrate emerging markets in Africa and Asia
Use vast experience and research about pharmaceuticals giving them a competitive edge on others to develop new products In the changing world of increased illness there is always opportunity to find new drugs that have not yet been discovered by other pharmaceutical companies Possible partnerships and mergers with other pharmaceutical companies would achieve better results in the drug development and would reduce competition Threats
Conducting research and development without any significant results Undesirable effects of their products like Advantia may lead to less credibility in the future Huge competition from other pharmaceutical companies such as Pfizer, Novartis and Bristol-Myers Squibb. Increasing demand of genetic drugs leads to a higher demand of low prices from consumers.
After analyzing the GSK SWOT analysis it is clear to see that this company will continue to be one of the leading...
Please join StudyMode to read the full document